In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...
The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies ...
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the ...
Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio’s management teamHOUSTON, Dec.
A proposed development at the Riverside MBTA station in Newton has won city permitting approval for 755 residential units — ...
IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative ...
Pharmaceutical Technology on MSN
AGC Biologics to expand cell line development with ATUM partnership
AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.
Also on Thursday, Zealand held its Capital Markets Day in London, outlining the strategy for its weight management franchise ...
Capital has become discerning. The inflated valuations of 2021 have given way to a more disciplined environment where ...
Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...
Dr. Abribat has a proven track record of developing innovative treatments for rare diseases, achieving three successful biotech/company exits He is a seasoned scientific and operational leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results